Our mission is the stabilization of sensitive biochemical and molecular reagents for applications in diagnostics and research. The core technology for this purpose is freeze-drying, also referred to as lyophilization – a field where we at Appylo have extensive experience in development and production. But we also offer other methods of reagent stabilization.
Â
Freeze-drying is a dehydration process through sublimation, i.e. the phase transition of water from solid directly to vapour. This is possible when temperature and pressure are below the triple-point in the phase diagram of water. Below that point, water is gently removed from a frozen aqueous sample by sublimation. Simultaneously, the molecules are stabilized by lyoprotectans, polymers and other excipients which conserve the shape of the product and facilitate fast resuspension. Therefore lyophilization is the method of choice for stabilization of products which contain thermo-instable and expensive substances. Rapid rehydration before application as it is required by mostmolecular biology assays. is assured by the high porous structure of the lyophilizate.
Although the lyophilization process is time and energy consuming, the total CO2 footprint of freeze-dried : Cold chains for storage and distribution are not required any more.
Freeze-drying has become a fast-growing segment in the field of IVD reagents even before the SARS-CoV-2 pandemic. The increasing demand for high-performance reagents makes lyophilization the key technology for supply of high-performance therapeutic drugs, vaccines as wells as enzymes, proteins and nucleic acids. Lyophilization also enables new possibilities for complex reagent formulations that are unstable in liquid form.
Freeze-drying technology typically used in pharmaceutical or diagnostics industry requires the conventional flasks closed by stoppers or plastic reaction tubes which limits upscaling possibilities. We have overcome this common obstacle of freeze-drying technology with our proprietary production technology.
With SARS-CoV-2 a transformation in diagnostics from centralized and professional testing to decentral Point-of-Care (PoC) or individual Point-of-Need (PoN) testing has accelerated. For testing outside laboratories and thus in uncontrolled environments by semi-skilled or even untrained users lyophilization is the means of choice: Pre-packed single-portioned, ready-to-use reactions and no need for cold-chains are prerequisites for PoC- or PoN-solutions.
The challenge remains in the design of devices such as cartridge consumables and disposables for easy-to-use kits.
For freeze-drying of reagents excipients are used to stabilize the products shelf-life and give it  a mechanically stable shape as well as a porous structure for e.g. pick-and-placing and fast resuspension behavior. After the lyophilization process lyo cakes remain in the containers chosen for freeze-drying. These can now be stored and handled at ambient temperature.
Applyo’s proprietary technology renders containers unnecessary for freeze-drying, thereby increasing the freeze-drying capacity of the machines substantially. Furthermore, Applyo Beads are single-apportionable and can be picked and placed as required due to their high mechanical stability.
Applyo Beads produced with our proprietary freeze-drying technology differ from lyo cakes  manufactured in conventional freeze-drying technology by various characteristics:
Conventional freeze-drying approach
Applyo‘s freeze-drying approach
With our current technology a single freeze-dryer is able to produce 120,000 Applyo Beads per batch and day. To meet future requirements and the growing demand for even larger quantities of freeze-dried reagents, we are working on a new innovative, proprietary high through-put lyophilization-production technology (patent pending soon). The final capacity will be 2,000,000 Applyo Beads per batch and day. By now we have demonstrated the technology for 400,000 Applyo Beads per batch. Please stay tuned for updates…
We offer also a variety of technologies for air-, heat- and vacuum-drying of reagents as well as powder compaction (tableting) of dry reagents.
Our mission is the stabilization of sensitive biochemical and molecular reagents for applications in diagnostics and research. The core technology for this purpose is freeze-drying, also referred to as lyophilization – a field where we at Appylo have extensive experience in development and production. But we also offer other methods of reagent stabilization.
Â
Freeze-drying is a dehydration process through sublimation, i.e. the phase transition of water from solid directly to vapour. This is possible when temperature and pressure are below the triple-point in the phase diagram of water. Below that point, water is gently removed from a frozen aqueous sample by sublimation. Simultaneously, the molecules are stabilized by lyoprotectans, polymers and other excipients which conserve the shape of the product and facilitate fast resuspension. Therefore lyophilization is the method of choice for stabilization of products which contain thermo-instable and expensive substances. Rapid rehydration before application as it is required by mostmolecular biology assays. is assured by the high porous structure of the lyophilizate.
Although the lyophilization process is time and energy consuming, the total CO2 footprint of freeze-dried : Cold chains for storage and distribution are not required any more.
Freeze-drying has become a fast-growing segment in the field of IVD reagents even before the SARS-CoV-2 pandemic. The increasing demand for high-performance reagents makes lyophilization the key technology for supply of high-performance therapeutic drugs, vaccines as wells as enzymes, proteins and nucleic acids. Lyophilization also enables new possibilities for complex reagent formulations that are unstable in liquid form.
Freeze-drying technology typically used in pharmaceutical or diagnostics industry requires the conventional flasks closed by stoppers or plastic reaction tubes which limits upscaling possibilities. We have overcome this common obstacle of freeze-drying technology with our proprietary production technology.
With SARS-CoV-2 a transformation in diagnostics from centralized and professional testing to decentral Point-of-Care (PoC) or individual Point-of-Need (PoN) testing has accelerated. For testing outside laboratories and thus in uncontrolled environments by semi-skilled or even untrained users lyophilization is the means of choice: Pre-packed single-portioned, ready-to-use reactions and no need for cold-chains are prerequisites for PoC- or PoN-solutions.
The challenge remains in the design of devices such as cartridge consumables and disposables for easy-to-use kits.
For freeze-drying of reagents excipients are used to stabilize the products shelf-life and give it  a mechanically stable shape as well as a porous structure for e.g. pick-and-placing and fast resuspension behavior. After the lyophilization process lyo cakes remain in the containers chosen for freeze-drying. These can now be stored and handled at ambient temperature.
Applyo’s proprietary technology renders containers unnecessary for freeze-drying, thereby increasing the freeze-drying capacity of the machines substantially. Furthermore, Applyo Beads are single-apportionable and can be picked and placed as required due to their high mechanical stability.
Applyo Beads produced with our proprietary freeze-drying technology differ from lyo cakes  manufactured in conventional freeze-drying technology by various characteristics:
Conventional freeze-drying approach
Applyo‘s freeze-drying approach
With our current technology a single freeze-dryer is able to produce 120,000 Applyo Beads per batch and day. To meet future requirements and the growing demand for even larger quantities of freeze-dried reagents, we are working on a new innovative, proprietary high through-put lyophilization-production technology (patent pending soon). The final capacity will be 2,000,000 Applyo Beads per batch and day. By now we have demonstrated the technology for 400,000 Applyo Beads per batch. Please stay tuned for updates…
We offer also a variety of technologies for air-, heat- and vacuum-drying of reagents as well as powder compaction (tableting) of dry reagents.
Applyo Jena GmbH
Göschwitzer Straße 22
07745 Jena
Deutschland
Phone: +49 (0)3641 554 788-0
Fax: +49 (0)3641 554 788-1
E-Mail: info@applyo-jena.com
Web: www.applyo-jena.com
Manufacturer of molecular biology reagent mixtures for research and development laboratories, as well as reagent and diagnostics manufacturers – stable at room temperature and suitable for immediate use.
→ Imprint
→ Privacy Policy
→ Cookie Policy
→ Terms & Conditions
→ Cancellation policy
Â
Applyo Jena GmbH
Göschwitzer Straße 22
07745 Jena
Deutschland
Phone: +49 (0)3641 554 788-0
Fax: +49 (0)3641 554 788-1
E-Mail: info@applyo-jena.com
Web: www.applyo-jena.com
Manufacturer of molecular biology reagent mixtures for research and development laboratories, as well as reagent and diagnostics manufacturers – stable at room temperature and suitable for immediate use.
→ Imprint
→ Privacy Policy
→ Cookie Policy
→ Terms & Conditions
→ Cancellation policy
Â
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.